Peer-reviewedCC BYFrontiers in pharmacology
Efficacy and safety of P2X3 receptor antagonists in refractory or unexplained chronic cough: an updated systematic review and meta-analysis
- 1Hunan University of Chinese Medicine , ,
- 2Affiliated Hospital of Hunan Academy of Chinese Medicine , ,
Related
- The efficacy of NMDA receptor antagonists in neuropsychiatric and non-motor symptoms of Parkinson’s disease: a systematic review
- Efficacy and safety of novel non-steroidal mineralocorticoid receptor antagonists in diabetic kidney disease: an updated systematic review and meta-analysis of randomized controlled trials
- Peripherally acting μ-opioid receptor antagonists for recovery of bowel function after radical cystectomy: a systematic review and meta-analysis
- Effects of Renin–Angiotensin Inhibitors, Sodium–Glucose Cotransporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists and Glucagon‐Like Peptide 1 Receptor Agonists on Kidney Outcomes in Patients With Type 1 Diabetes: A Systematic Review and Meta‐Analysis
- Orexin receptor antagonists for sleep disturbance in attention-deficit/hyperactivity disorder and autism spectrum disorder: a systematic review
BibTeX
@article{an2026efficacy,
title = {{Efficacy and safety of P2X3 receptor antagonists in refractory or unexplained chronic cough: an updated systematic review and meta-analysis}},
author = {Yu-Tong An and Shu-Ze Tang and Yi Luo and Le Huang and Xiu-Juan Deng},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13657972},
note = {CC BY},
}
RIS
TY - JOUR
TI - Efficacy and safety of P2X3 receptor antagonists in refractory or unexplained chronic cough: an updated systematic review and meta-analysis
AU - Yu-Tong An
AU - Shu-Ze Tang
AU - Yi Luo
AU - Le Huang
AU - Xiu-Juan Deng
PY - 2026
DA - 2026/10/16
JO - Frontiers in pharmacology
UR - https://europepmc.org/article/PMC/PMC13657972
SN - 1663-9812
ER -